Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: A case report

Kosuke Sagara, Kotoe Takayoshi, Eiji Kusumoto, Keita Uchino, Taisei Matsumura, Hitoshi Kusaba, Seiya Momosaki, Koji Ikejiri, Eishi Baba

Research output: Contribution to journalArticle

Abstract

Background: Retroperitoneal sarcomas (RPS), such as pleomorphic leiomyosarcoma, often invade or displace vital organs in the abdominal cavity and exhibit an aggressive clinical course. Complete surgical resection of the tumor and preoperative radiotherapy and chemotherapies can be used for non-metastatic RPS. However, in case of huge retroperitoneal sarcoma fully occupying the abdominal cavity, surgical resection tends to be insufficient, resulting in poor outcomes. This report describes a case of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma that was favorably controlled by debulking surgery followed by combination chemotherapy and radiotherapy. Case presentation. A 65-year-old Japanese woman developed abdominal discomfort due to a huge retroperitoneal tumor fully occupying the abdominal cavity. The immunohistochemical diagnosis was pleomorphic leiomyosarcoma with high-grade malignancy and aggressive proliferative features. Debulking surgery could be performed, but the small residual tumor had rapidly grown to an approximately 22 cm in length on the major axis within 38 days after the operation. The patient's general condition progressively declined. Combination chemotherapy, consisting of doxorubicin and ifosfamide, was successfully administered for six cycles while maintaining dose intensity. The best objective response was a partial response, and the chemotherapy was well tolerated. Approximately 50 Gy of radiotherapy was delivered to the remaining tumor. This multimodal strategy resulted in progression-free survival for more than 17 months and achieved sustained symptomatic relief. Conclusions: Multimodal therapy with debulking surgery, combination chemotherapy and radiotherapy controlled a rapidly progressive retroperitoneal pleomorphic leiomyosarcoma. Maintaining dose intensity of the chemotherapy and radiotherapy might contribute to overall tumor control.

Original languageEnglish
Article number377
JournalBMC research notes
Volume7
Issue number1
DOIs
Publication statusPublished - Jun 19 2014

Fingerprint

Chemotherapy
Leiomyosarcoma
Radiotherapy
Tumors
Abdominal Cavity
Combination Drug Therapy
Sarcoma
Surgery
Neoplasms
Drug Therapy
Therapeutics
Ifosfamide
Residual Neoplasm
Doxorubicin
Disease-Free Survival
Dosimetry

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy : A case report. / Sagara, Kosuke; Takayoshi, Kotoe; Kusumoto, Eiji; Uchino, Keita; Matsumura, Taisei; Kusaba, Hitoshi; Momosaki, Seiya; Ikejiri, Koji; Baba, Eishi.

In: BMC research notes, Vol. 7, No. 1, 377, 19.06.2014.

Research output: Contribution to journalArticle

Sagara, Kosuke ; Takayoshi, Kotoe ; Kusumoto, Eiji ; Uchino, Keita ; Matsumura, Taisei ; Kusaba, Hitoshi ; Momosaki, Seiya ; Ikejiri, Koji ; Baba, Eishi. / Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy : A case report. In: BMC research notes. 2014 ; Vol. 7, No. 1.
@article{18eef9d2dc4340ed80511bdd75a07e3d,
title = "Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy: A case report",
abstract = "Background: Retroperitoneal sarcomas (RPS), such as pleomorphic leiomyosarcoma, often invade or displace vital organs in the abdominal cavity and exhibit an aggressive clinical course. Complete surgical resection of the tumor and preoperative radiotherapy and chemotherapies can be used for non-metastatic RPS. However, in case of huge retroperitoneal sarcoma fully occupying the abdominal cavity, surgical resection tends to be insufficient, resulting in poor outcomes. This report describes a case of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma that was favorably controlled by debulking surgery followed by combination chemotherapy and radiotherapy. Case presentation. A 65-year-old Japanese woman developed abdominal discomfort due to a huge retroperitoneal tumor fully occupying the abdominal cavity. The immunohistochemical diagnosis was pleomorphic leiomyosarcoma with high-grade malignancy and aggressive proliferative features. Debulking surgery could be performed, but the small residual tumor had rapidly grown to an approximately 22 cm in length on the major axis within 38 days after the operation. The patient's general condition progressively declined. Combination chemotherapy, consisting of doxorubicin and ifosfamide, was successfully administered for six cycles while maintaining dose intensity. The best objective response was a partial response, and the chemotherapy was well tolerated. Approximately 50 Gy of radiotherapy was delivered to the remaining tumor. This multimodal strategy resulted in progression-free survival for more than 17 months and achieved sustained symptomatic relief. Conclusions: Multimodal therapy with debulking surgery, combination chemotherapy and radiotherapy controlled a rapidly progressive retroperitoneal pleomorphic leiomyosarcoma. Maintaining dose intensity of the chemotherapy and radiotherapy might contribute to overall tumor control.",
author = "Kosuke Sagara and Kotoe Takayoshi and Eiji Kusumoto and Keita Uchino and Taisei Matsumura and Hitoshi Kusaba and Seiya Momosaki and Koji Ikejiri and Eishi Baba",
year = "2014",
month = "6",
day = "19",
doi = "10.1186/1756-0500-7-377",
language = "English",
volume = "7",
journal = "BMC Research Notes",
issn = "1756-0500",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Favorable control of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma with multimodality therapy

T2 - A case report

AU - Sagara, Kosuke

AU - Takayoshi, Kotoe

AU - Kusumoto, Eiji

AU - Uchino, Keita

AU - Matsumura, Taisei

AU - Kusaba, Hitoshi

AU - Momosaki, Seiya

AU - Ikejiri, Koji

AU - Baba, Eishi

PY - 2014/6/19

Y1 - 2014/6/19

N2 - Background: Retroperitoneal sarcomas (RPS), such as pleomorphic leiomyosarcoma, often invade or displace vital organs in the abdominal cavity and exhibit an aggressive clinical course. Complete surgical resection of the tumor and preoperative radiotherapy and chemotherapies can be used for non-metastatic RPS. However, in case of huge retroperitoneal sarcoma fully occupying the abdominal cavity, surgical resection tends to be insufficient, resulting in poor outcomes. This report describes a case of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma that was favorably controlled by debulking surgery followed by combination chemotherapy and radiotherapy. Case presentation. A 65-year-old Japanese woman developed abdominal discomfort due to a huge retroperitoneal tumor fully occupying the abdominal cavity. The immunohistochemical diagnosis was pleomorphic leiomyosarcoma with high-grade malignancy and aggressive proliferative features. Debulking surgery could be performed, but the small residual tumor had rapidly grown to an approximately 22 cm in length on the major axis within 38 days after the operation. The patient's general condition progressively declined. Combination chemotherapy, consisting of doxorubicin and ifosfamide, was successfully administered for six cycles while maintaining dose intensity. The best objective response was a partial response, and the chemotherapy was well tolerated. Approximately 50 Gy of radiotherapy was delivered to the remaining tumor. This multimodal strategy resulted in progression-free survival for more than 17 months and achieved sustained symptomatic relief. Conclusions: Multimodal therapy with debulking surgery, combination chemotherapy and radiotherapy controlled a rapidly progressive retroperitoneal pleomorphic leiomyosarcoma. Maintaining dose intensity of the chemotherapy and radiotherapy might contribute to overall tumor control.

AB - Background: Retroperitoneal sarcomas (RPS), such as pleomorphic leiomyosarcoma, often invade or displace vital organs in the abdominal cavity and exhibit an aggressive clinical course. Complete surgical resection of the tumor and preoperative radiotherapy and chemotherapies can be used for non-metastatic RPS. However, in case of huge retroperitoneal sarcoma fully occupying the abdominal cavity, surgical resection tends to be insufficient, resulting in poor outcomes. This report describes a case of rapidly progressive retroperitoneal pleomorphic leiomyosarcoma that was favorably controlled by debulking surgery followed by combination chemotherapy and radiotherapy. Case presentation. A 65-year-old Japanese woman developed abdominal discomfort due to a huge retroperitoneal tumor fully occupying the abdominal cavity. The immunohistochemical diagnosis was pleomorphic leiomyosarcoma with high-grade malignancy and aggressive proliferative features. Debulking surgery could be performed, but the small residual tumor had rapidly grown to an approximately 22 cm in length on the major axis within 38 days after the operation. The patient's general condition progressively declined. Combination chemotherapy, consisting of doxorubicin and ifosfamide, was successfully administered for six cycles while maintaining dose intensity. The best objective response was a partial response, and the chemotherapy was well tolerated. Approximately 50 Gy of radiotherapy was delivered to the remaining tumor. This multimodal strategy resulted in progression-free survival for more than 17 months and achieved sustained symptomatic relief. Conclusions: Multimodal therapy with debulking surgery, combination chemotherapy and radiotherapy controlled a rapidly progressive retroperitoneal pleomorphic leiomyosarcoma. Maintaining dose intensity of the chemotherapy and radiotherapy might contribute to overall tumor control.

UR - http://www.scopus.com/inward/record.url?scp=84902716362&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902716362&partnerID=8YFLogxK

U2 - 10.1186/1756-0500-7-377

DO - 10.1186/1756-0500-7-377

M3 - Article

C2 - 24947892

AN - SCOPUS:84902716362

VL - 7

JO - BMC Research Notes

JF - BMC Research Notes

SN - 1756-0500

IS - 1

M1 - 377

ER -